A direct injection HPLC method for the simultaneous measurement of dyphylline and doxofylline in serum is reported.
monitored. Only 10 L of serum is required to detect less than 1 mg of each drug per liter in biological samples. The standard curve for the method is linear over the range 6-100 mg/L, and precision is acceptable for both drugs, with CVs of especially in sustained-release preparations, is widely prescribed in the therapy of asthma (1) . Among the theophylline analogs recently introduced for such therapy are dihydroxypropyl theophylline (dyphylline) and 2-(7'-theophyllinemethyl)-1,3-dioxolane (doxof'lline), which are claimed to retain the therapeutic properties of theophylline but have a lower incidence of side effects (2) (3) (4) . However, they have encountered limited success, mainly because of the difficulty of adequately monitoring their concentrations in patients' sera. Indeed, no immunoassays are available for determination of these drugs, and chromatographic methods are too complex for routine use in clinical laboratories (5) (6) (7) .
In this paper we describe a very simple HPLC method, not requiring sample treatment, for simultaneously determining dyphylline and doxorlline.
The method is comparable with immunoassays in terms of operating simplicity, while retaining the precision, accuracy, and ruggedness of chromatographic methods. and "HPLC" grade water were purchased from Carlo Erba, Milano, Italy. Serum and plasma were used either fresh or after storage at -20 #{176}C. For sample clean-up we used 0.45-pPm (pore size) disposable ifiters purchased from Millipore, Bedford, MA.
Materials and Methods

Reagents
Apparatus.
The isocratic HPLC system we used was composed of a Jasco (Tokyo, Japan) Model 880-PU HPLC pump, a 7125 Rheodyne (Cotati, CA) irjector equipped with a 10-giL loop, a Jasco Model 875 ultraviolet detector, and a Model 3390 A integrator (Hewlett-Packard, Palo Alto, CA). We used an "internal surface reversed phase Pinkerton" column (150 x 4.6 mm) from Regis Chemical Co., Morton Grove, IL, packed with 5-.an silica particles derivatized with glycine-phenylalanine-phenylalanine.
A Type 73XX column inlet filter (0.5-pm pore size, 3 mm diameter;
Rheodyne)
was connected between the injector and the
column.
Chromatographic conditions and sample preparation. We used a mobile phase of phosphate buffer (0.1 mol/L, pH 6.8) at a flow rate of 0.3 mL/min, at room temperature.
The ultraviolet detector was set at 275 nm with a full-scale deflection of0.08A. To reduce the risk of column clogging, we periodically reversed the column according to the manufacturer's recommendations. Fresh samples (either serum or plasma) were filtered through 0.45-pm (pore size) disposable filters and injected. Samples that had been frozen were centrifuged before ifitration.
Results
Under the described conditions, dyphylline and doxofylline were eluted in quite symmetrical peaks and were well resolved from each other and from the peaks for theophylline and caffeine (Figure 1) . Nevertheless, the efficiency of the column apparently depended on flow rate in the range 0.1-1 mL/min, suggesting problems with the mass transfer as reported by Cook and Pinkerton (8). Thus, we used a relatively low flow rate, 0.3 mU/mm, which still assures acceptable retention times. In practice, samples could be injected every 15 min.
Retention times for dyphylline and doxofylline were 8.43 and 13.94 mm, respectively. Coefficients of variation (CVs) were respectively 2.6% and 4.0% during the same day (n = 5) and 9.6% and 9.2% for different days (n = 5).
The linearity of response was calculated over the range 6-100 mg/L. The calibration curve data, obtained with serum with added dyphylline and doxofylline, were analyzed by a least-squares regression method, giving the following equations: y = 20752x -6565 andy = 17615x -17707 for dyphylline and doxofylline, respectively, where x is the concentration in mgfL and y is the peak area in arbitrary units. For both drugs a close parallelism was observed between calibration curves prepared from samples in serum and in buffer (Figure 2) .
Because no extraction procedures requiring the monitoring of the recovery were involved, we used external standardization, interpolating the concentrations of unknown The reproducibility (CV) of results, evaluated at two concentrations (6.2 and 25 mg/L, five replicates each) was 2.05% and 1.5% for dyphylline and 2.10% and 1.5% for doxofylline.
The classical definition of minimum detectable quantity-i.e., twicethe instrumentalnoise-does not fit with our chromatographic system when real samples are injected. In this case the main factor limiting sensitivity is the negative drift of the baseline, owing to the tail of the "front peak" caused by endogenous components. This hampers the use of sensitivity ranges lower than 0.08 A. Under these conditions instrumental noise is not measurable.
The limit of detection (defined as the least concentration of drug giving a peak surely distinguishable from other peaks of the matrix) was less than 1 mgfL for each drug, whether in serum or in plasma. Table 1 lists more than 70 drugs that, in a concentration of 20 mg/L, did not interfere in the HPLC determination of dyphylline and doxofylline (i.e., no spurious peaks were detectable at the retention times of dyphylline and doxofylline). 
DiscussIon
12
) and is suitable for both therapeutic drug monitoring and pharmacokinetics studies. Because the specificity of the assay, in the absence of any extraction procedure, relies on the chromatographic separation, we have given special care to examining the possibility of co-eluting peaks. Theophylline and caffeine are well resolved from dyphylline and doxofylline, and none of 76 drugs we examined (Table 1) has shown significant interferences.
However, paracetamol (acetaminophen) partly overlaps the theophylline peak. According to Dawson et al. (13) , use of a 250-mm-long column should resolve the problem.
It has been suggested that strong protein binding theeretically could hamper the use of direct-injection HPLC methods because of disturbances of the absorption equilibria of the analytes (9). The parallelism between the calibration curve for both the drugs, in buffer and in serum, suggests that they are not so strongly linked to proteins as to interfere with separation on this column.
We saw no significant decrement in column performance or pressure increase after more than 500 injections of samples. We consider this direct-injection HPLC method a simple, quick, accurate, and inexpensive way to measure methylxanthines of therapeutic interest.
